Search - tctmd.com

Displaying 821 - 840 of 1172

Sort: Relevancy | Date

Presentation Fellows 2016

Antithrombin Pharmacology for the Interventionalist

Presenter: Jeffrey W. Moses, David J. Cohen

April 16, 2016

Presentation Fellows 2016

Rationale for Revascularization in Stable Ischemic Heart Disease

Presenter: Ajay Kirtane

April 15, 2016

News Conference News ACC 2016

New Insights Into MitraClip Performance in Both Functional and Degenerative MR Subtypes, as Use Expands

Shelley Wood

April 12, 2016

News Conference News ACC 2016

Hints of What’s to Come in New Coronary Revascularization AUC

Caitlin E. Cox

April 12, 2016

News Conference News ACC 2016

CABG Beats Medical Therapy in CAD Patients With Severe LV Dysfunction: STICH 10-Year Results

Shelley Wood

April 08, 2016

News Conference News ACC 2016

Valve Hemodynamic Deterioration Post-TAVR Is Rare, Not Linked With Adverse Cardiovascular Outcomes

Michael O'Riordan

April 07, 2016

News Conference News ACC 2016

Women Have Same Cardiac Symptoms as Men, but Describe Them Differently, Influencing Testing Choices

L.A. McKeown

April 03, 2016

News Conference News ACC 2016

EARLY-BAMI: No Reduction in Infarct Size With IV Metoprolol Before Primary PCI

Caitlin E. Cox

April 03, 2016

News Daily News

AHA Issues Statement on Wearable Defibrillators, Cautions That Effectiveness Data Are Limited

Michael O'Riordan

March 31, 2016

News Daily News

美国指南更新，将接受 DES 的稳定患者的 DAPT 持续时间从 12 个月下调为 6 个月

Yael L. Maxwell

March 30, 2016

News Daily News

Updated US Guidelines Lower DAPT Duration From 12 to 6 Months in Stable Patients Receiving DES

Yael L. Maxwell

March 30, 2016

News Daily News

Las Últimas Directrices Norteamericanas Reducen la Duración del Tratamiento Antiplaquetario Doble de 12 a 6 Meses en Pacientes Estables que Reciben un SLF

Yael L. Maxwell

March 30, 2016

News Daily News

Absorb BVS: Safety, Efficacy, and Stent Thrombosis Tackled in Two New Analyses

Michael O'Riordan

March 30, 2016

News Daily News

Evidence Mounts Showing No Increased Risk of Heart Failure With Incretin-Based Antidiabetic Drugs

Michael O'Riordan

March 25, 2016

News Features

Hopes and Hype Await New Coronary Revascularization Appropriate Use Criteria in 2016

Caitlin E. Cox

March 21, 2016

News Daily News

Scoring System Simplifies Risk Assessment for Sudden Cardiac Death After NSTE ACS

L.A. McKeown

March 18, 2016

News Daily News

Amid Soaring CAD in China, Rates of Catheterization and PCI Begin to Mount

Leah Lawrence

March 18, 2016

News Daily News

FDA Panel Overwhelmingly Supports Absorb Bioresorbable Stent

Michael O'Riordan

March 16, 2016

News Daily News

FDA Review of Absorb Bioresorbable Stent Does Not Tip Hand Ahead of Tomorrow’s Advisory Panel Meeting

Michael O'Riordan

March 14, 2016

Presentation Intravascular Coronary Imaging and Physiology 2016

CT Imaging in Ischemic Heart Disease: CTA, CT-FFR, and CT-Perfusion – Current Uses and Future Projections

Presenter: Nathaniel Reichek

March 10, 2016

Advertisement

Antithrombin Pharmacology for the Interventionalist

Rationale for Revascularization in Stable Ischemic Heart Disease

New Insights Into MitraClip Performance in Both Functional and Degenerative MR Subtypes, as Use Expands

Hints of What’s to Come in New Coronary Revascularization AUC

CABG Beats Medical Therapy in CAD Patients With Severe LV Dysfunction: STICH 10-Year Results

Valve Hemodynamic Deterioration Post-TAVR Is Rare, Not Linked With Adverse Cardiovascular Outcomes

Women Have Same Cardiac Symptoms as Men, but Describe Them Differently, Influencing Testing Choices

EARLY-BAMI: No Reduction in Infarct Size With IV Metoprolol Before Primary PCI

AHA Issues Statement on Wearable Defibrillators, Cautions That Effectiveness Data Are Limited

美国指南更新，将接受 DES 的稳定患者的 DAPT 持续时间从 12 个月下调为 6 个月

Updated US Guidelines Lower DAPT Duration From 12 to 6 Months in Stable Patients Receiving DES

Las Últimas Directrices Norteamericanas Reducen la Duración del Tratamiento Antiplaquetario Doble de 12 a 6 Meses en Pacientes Estables que Reciben un SLF

Absorb BVS: Safety, Efficacy, and Stent Thrombosis Tackled in Two New Analyses

Evidence Mounts Showing No Increased Risk of Heart Failure With Incretin-Based Antidiabetic Drugs

Hopes and Hype Await New Coronary Revascularization Appropriate Use Criteria in 2016

Scoring System Simplifies Risk Assessment for Sudden Cardiac Death After NSTE ACS

Amid Soaring CAD in China, Rates of Catheterization and PCI Begin to Mount

FDA Panel Overwhelmingly Supports Absorb Bioresorbable Stent

FDA Review of Absorb Bioresorbable Stent Does Not Tip Hand Ahead of Tomorrow’s Advisory Panel Meeting

CT Imaging in Ischemic Heart Disease: CTA, CT-FFR, and CT-Perfusion – Current Uses and Future Projections

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content